None listed
Conditions
Interventions
Intervention 1: For each patient 10 second subcutaneous injection, will be performed and 12 hours later, 30 second injection perform for the same patient. Intervention 2: For each patient 30 second su
Treatment - Other
For each patient 10 second subcutaneous injection, will be performed and 12 hours later, 30 second injection perform for the same patient.
For each patient 30 second subcutaneous injection, will be performed and 12 hours later, 10 second injection perform for the same patient.
Sponsors
Golestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Being a patient for heparin subcutaneous injection; conscious enough to participate and not manipulate injection area by rubbing, scratching and touching the injection site. Exclusion criteria: Discontinuation of subcutaneous injection of heparin or discharge patients within 48 hours, unilateral sensory and neurological defect, any type of skin lesion barrier to assessing bruising, allergic disease, pregnant patients, hematological diseases and the patients who had been given any other injections at the arm site apart from heparin during the days of the research
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: 48 to 60 hours after injection. Method of measurement: Visual? Analog Scale.;Extent of bruising. Timepoint: 48 to 60 hours after injection. Method of measurement: Using flexible transparent Ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkram Sanagoo PHD
Golestan University Of Medical Sciences
Outcome results
None listed